Evidence map›Paper›PMID 42645371›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

Clinical Characteristics and Prognostic Analysis of EBV-Positive HIV-Associated Diffuse Large B-Cell Lymphoma in China: A Retrospective Single-Center Study.

Lizhi Feng, Haolan He, Han Zhao, Bo Liu, Zhimin Chen, Xinhua Liu, Haisheng Yu, Fengyu Hu, Xiaoping Tang, Linghua Li

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lizhi FengInfectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.ORCID 0009-0004-9347-0825
Haolan HeInfectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
Han ZhaoInfectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
Bo LiuInfectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
Zhimin ChenInfectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
Xinhua LiuInfectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
Haisheng YuInstitute of Infectious Disease, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.ORCID 0000-0002-1757-1411
Fengyu HuInstitute of Infectious Disease, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
Xiaoping TangInfectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
Linghua LiInfectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.ORCID 0000-0001-5711-8681

Funding

Joint Funding Project of the Guangzhou Municipal Science and Technology Bureau and Guangzhou Medical University/Guangzhou Eighth People's Hospital 2025A03J3908, 2025A03J3902National Key Research and Development Program of China 2024YFC2311100Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project 2025ZD01905004,2026ZD01911605
6 · The paper itself

Abstract

Epstein-Barr virus (EBV) contributes to human immunodeficiency virus (HIV)-associated diffuse large B-cell lymphoma (DLBCL) pathogenesis. We retrospectively analyzed clinical features and outcomes of EBV-positive (

Indexed as

Epstein-Barr Virus InfectionsHerpesvirus 4, HumanHIV InfectionsLymphoma, Large B-Cell, DiffuseAdultChinaFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesEpstein–Barr virushuman immunodeficiency virus-associated diffuse large B-cell lymphomainfectionprognosisrisk stratification

Identifiers

PMID42645371
PMCPMC13510999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.